Network meta-analysis of first-line immune checkpoint inhibitor therapy in advanced non-squamous non-small cell lung cancer patients with PD-L1 expression &#8805; 50.

Chen, Wei; Chen, Jiayi; Zhang, Lin; Cheng, Sheng; Yu, Junxian

Network meta-analysis of first-line immune checkpoint inhibitor therapy in advanced non-squamous non-small cell lung cancer patients with PD-L1 expression ≥ 50.

Chen, Wei; Chen, Jiayi; Zhang, Lin; Cheng, Sheng; Yu, Junxian.

Afiliação

Chen W; Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Chen J; School of Nursing, Capital Medical University, Beijing, China.
Zhang L; Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Cheng S; Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Yu J; Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China. junxianyu@ccmu.edu.cn.

BMC Cancer ; 23(1): 791, 2023 Aug 23.

Article em En | MEDLINE | ID: mdl-37612622

Assuntos

Carcinoma Pulmonar de Células não Pequenas; Neoplasias Pulmonares; Humanos; Carcinoma Pulmonar de Células não Pequenas/tratamento farmacológico; Antígeno B7-H1; Inibidores de Checkpoint Imunológico/uso terapêutico; Metanálise em Rede; Revisões Sistemáticas como Assunto; Neoplasias Pulmonares/tratamento farmacológico

Palavras-chave

Immune checkpoint inhibitors (ICIs); Network meta-analysis (NMA); Non-small cell lung cancer (NSCLC); Programmed cell death ligand-1 (PD-L1); Programmed cell death-1 (PD-1)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google